IL6 and breast carcinoma: The GPR30 antagonist G15 (Figure 1e–h) or PTX toxin, a G-protein (αi) inhibitor (Figure S1), inhibited all the proliferative effects, suggesting the GPR30 participation in the proliferation stimulated by E2 and IL-6 in breast cancer cells.